CGP60474
目录号: PL09906 纯度: ≥98%
CAS No. :164658-13-3
商品编号 规格 价格 会员价 是否有货 数量
PL09906-5mg 5mg ¥1768.00 请登录
PL09906-10mg 10mg ¥2764.00 请登录
PL09906-50mg 50mg ¥10286.00 请登录
PL09906-100mg 100mg ¥13661.00 请登录
PL09906-200mg 200mg 询价 询价
PL09906-500mg 500mg 询价 询价
PL09906-10mM*1mLinDMSO 10mM*1mLinDMSO ¥1944.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
CGP60474
中文别名
3-[[4-[2-[(3-氯苯基)氨基]-4-嘧啶基]-2-吡啶基]氨基]-1-丙醇
英文名称
CGP60474
英文别名
1-Propanol,3-[[4-[2-[(3-chlorophenyl)amino]-4-pyrimidinyl]-2-pyridinyl]amino]-;CGP60474;3-[[4-[2-(3-chloroanilino)pyrimidin-4-yl]pyridin-2-yl]amino]propan-1-ol;1-Propanol, 3-((4-(2-((3-chlorophenyl)amino)-4-pyrimidinyl)-2-pyridinyl)amino)-;AC1LD8S6;CGP-60474;GNF-Pf-88;UNII-16IP6G5MLC;3-[[4-[2-[(3-Chlorophenyl)amino]-4-pyrimidinyl]-2-pyridinyl]amino]-1-propanol
Cas No.
164658-13-3
分子式
C18H18N5OCl
分子量
355.82
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
CGP60474 是一种高效的抗内毒素药物,是一种有效的细胞周期蛋白依赖激酶 (CDK) 抑制剂 (CDK1/B、CDK2/E、CDK2/a、CDK4/D、CDK5/p25、CDK7/H 和 CDK9/T 的 IC50 值分别为 26、3、4、216、10、200 和 13 nM)。CGP60474 是一种选择性和 ATP 竞争性 PKC 抑制剂。
生物活性
CGP60474, a highly potent anti-endotoxemic agent, is a potent cyclin-dependent kinase (CDK) inhibitor (IC 50 values are 26, 3, 4, 216, 10, 200 and 13 nM for CDK1/B, CDK2/E, CDK2/A, CDK4/D, CDK5/p25, CDK7/H and CDK9/T, respectively). CGP60474 is a selective and ATP-competitive PKC inhibitor.
性状
Solid
IC50 & Target[1][2]
PKC CDK1-Cyclin B 26 nM (IC50)
体外研究(In Vitro)
CGP60474 (Compound A) is a potent VEGFR-2 inhibitor, with an IC50 of 84 nM. CGP60474 is also a PKC inhibitor, with competitive kinetics relative to ATP. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
CGP-60474 (10?mg/kg; i.p.) inhibits the IL-6 level and increases the survival rate in the LPS endotoxemia model. has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: C57Bl/6 mice (LPS endo
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Jorda R, et al. How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?. J Med Chem. 2018;61(20):9105-9120.
[2]. Han HW, et al. LINCS L1000 dataset-based repositioning of CGP-60474 as a highly potent anti-endotoxemic agent. Sci Rep. 2018;8(1):14969. Published 2018 Oct 8.
溶解度数据
In Vitro: DMSO : ≥ 50 mg/mL (140.52 mM)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2